BEVACIZUMAB

BEVACIZUMAB was reported 125242 times

BEVACIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 524 0.4209
1 TUMOUR PERFORATION 120 0.3774
2 BACTERIAL ENDOPHTHALMITIS 86 0.3233
3 UROGENITAL FISTULA 70 0.2954
4 RADIATION NECROSIS 156 0.2723
5 GASTROINTESTINAL PERFORATION 1099 0.2641
6 COLORECTAL CANCER METASTATIC 597 0.2517
7 RECTAL PERFORATION 130 0.2412
8 HEPATIC ATROPHY 107 0.2388
9 PSEUDOCIRRHOSIS 74 0.2229
10 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 51 0.2217
11 DIABETIC RETINAL OEDEMA 108 0.2126
12 ENDOPHTHALMITIS 1233 0.2053
13 SUBRETINAL FLUID 224 0.2049
14 RETINAL PIGMENT EPITHELIAL TEAR 140 0.2017
15 ANASTOMOTIC LEAK 139 0.2003
16 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 172 0.1933
17 TUMOUR NECROSIS 197 0.1864
18 GLIOBLASTOMA 310 0.1815
19 ANASTOMOTIC COMPLICATION 59 0.1715
20 PROTEIN URINE 152 0.1680
21 RECTAL CANCER METASTATIC 58 0.1667
22 PROTEINURIA 3147 0.1654
23 NASAL SEPTUM PERFORATION 106 0.1638
24 BLEEDING VARICOSE VEIN 88 0.1627
25 OVARIAN CANCER RECURRENT 260 0.1617
26 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 133 0.1547
27 GLIOMA 96 0.1493
28 GASTROINTESTINAL ANASTOMOTIC LEAK 55 0.1410
29 PERFORATION 112 0.1390
30 SMALL INTESTINAL PERFORATION 260 0.1385
31 OESOPHAGEAL VARICES HAEMORRHAGE 296 0.1362
32 OVARIAN CANCER METASTATIC 113 0.1329
33 RETINAL THICKENING 217 0.1299
34 TUMOUR RUPTURE 73 0.1299
35 VISUAL ACUITY TESTS ABNORMAL 72 0.1295
36 DUODENAL PERFORATION 125 0.1273
37 ILEAL PERFORATION 83 0.1252
38 METASTASES TO PERITONEUM 316 0.1250
39 TUMOUR HAEMORRHAGE 356 0.1246
40 CATARACT NUCLEAR 82 0.1229
41 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 94 0.1202
42 COLON CANCER METASTATIC 185 0.1147
43 FEMALE GENITAL TRACT FISTULA 190 0.1112
44 RETINAL OEDEMA 212 0.1108
45 ENTEROCUTANEOUS FISTULA 96 0.1088
46 HEPATOCELLULAR CARCINOMA 809 0.1063
47 THERAPY RESPONDER 52 0.1059
48 RECTAL ADENOCARCINOMA 60 0.0992
49 MALIGNANT ASCITES 75 0.0978
50 GLIOBLASTOMA MULTIFORME 82 0.0974
51 LARGE INTESTINE PERFORATION 658 0.0947
52 VARICES OESOPHAGEAL 286 0.0945
53 METASTASES TO MENINGES 210 0.0923
54 WOUND DEHISCENCE 310 0.0917
55 PERITONEAL DISORDER 57 0.0880
56 PORTAL HYPERTENSION 271 0.0878
57 VITREOUS HAEMORRHAGE 241 0.0871
58 AGE-RELATED MACULAR DEGENERATION 132 0.0869
59 ALPHA 1 FOETOPROTEIN INCREASED 61 0.0857
60 INTESTINAL PERFORATION 961 0.0855
61 PERIPHERAL SENSORY NEUROPATHY 496 0.0848
62 PROTEIN URINE PRESENT 412 0.0826
63 CARCINOEMBRYONIC ANTIGEN INCREASED 159 0.0820
64 CHOROIDAL NEOVASCULARISATION 70 0.0816
65 CYSTOID MACULAR OEDEMA 153 0.0811
66 PRODUCT COUNTERFEIT 139 0.0805
67 IMMUNE-MEDIATED HEPATITIS 164 0.0802
68 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 112 0.0801
69 NON-INFECTIOUS ENDOPHTHALMITIS 68 0.0801
70 MICROANGIOPATHY 75 0.0798
71 METASTASES TO PLEURA 82 0.0782
72 RETINAL EXUDATES 72 0.0769
73 MACULAR FIBROSIS 52 0.0767
74 PELVIC ABSCESS 88 0.0766
75 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 94 0.0754
76 SUBILEUS 157 0.0753
77 VITRITIS 138 0.0745
78 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 58 0.0736
79 METASTASES TO LUNG 846 0.0732
80 ADENOCARCINOMA OF COLON 137 0.0731
81 LYMPHANGIOSIS CARCINOMATOSA 76 0.0729
82 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1631 0.0699
83 EMBOLISM ARTERIAL 84 0.0699
84 NON-SMALL CELL LUNG CANCER METASTATIC 59 0.0671
85 EMBOLISM 553 0.0665
86 MALIGNANT PLEURAL EFFUSION 112 0.0664
87 METASTASES TO LIVER 1149 0.0653
88 EMBOLISM VENOUS 196 0.0646
89 GASTROINTESTINAL FISTULA 56 0.0639
90 MYELOSUPPRESSION 2304 0.0639
91 CARBOHYDRATE ANTIGEN 125 INCREASED 218 0.0639
92 DISEASE PROGRESSION 7448 0.0629
93 STOMA SITE HAEMORRHAGE 96 0.0623
94 THERAPY PARTIAL RESPONDER 969 0.0621
95 GASTROINTESTINAL TOXICITY 295 0.0613
96 PORTAL VEIN THROMBOSIS 197 0.0609
97 MACULAR OEDEMA 340 0.0606
98 GASTRIC PERFORATION 165 0.0605
99 SKIN TOXICITY 339 0.0599
100 PERIPHERAL MOTOR NEUROPATHY 84 0.0599
101 NEPHROTIC SYNDROME 411 0.0599
102 RETINAL HAEMORRHAGE 418 0.0586
103 METASTASES TO SKIN 59 0.0571
104 METASTASES TO ADRENALS 52 0.0563
105 IMMUNE-MEDIATED ADVERSE REACTION 86 0.0560
106 NEUTROPENIC INFECTION 53 0.0554
107 METAMORPHOPSIA 102 0.0553
108 TOXIC ANTERIOR SEGMENT SYNDROME 60 0.0550
109 DEVICE RELATED THROMBOSIS 54 0.0548
110 ACQUIRED GENE MUTATION 71 0.0542
111 IMMUNE-MEDIATED LUNG DISEASE 97 0.0532
112 ASCITES 1564 0.0532
113 MACULAR HOLE 71 0.0529
114 MUCOSAL INFLAMMATION 1378 0.0526
115 VITREOUS DETACHMENT 114 0.0526
116 PERIRECTAL ABSCESS 58 0.0523
117 ARRHYTHMIA SUPRAVENTRICULAR 57 0.0522
118 LARGE INTESTINAL OBSTRUCTION 116 0.0519
119 HAEMATOTOXICITY 480 0.0505
120 GRANULOCYTE COUNT DECREASED 93 0.0501
121 BONE MARROW FAILURE 1011 0.0497
122 VENOUS THROMBOSIS 195 0.0496
123 DERMATITIS ACNEIFORM 300 0.0493
124 RETINAL DEGENERATION 64 0.0492
125 THROMBOTIC MICROANGIOPATHY 478 0.0490
126 BILE DUCT STENOSIS 58 0.0484
127 RECTAL ULCER 56 0.0477
128 METASTASES TO CENTRAL NERVOUS SYSTEM 613 0.0475
129 METASTASES TO LYMPH NODES 314 0.0465
130 BONE MARROW TOXICITY 55 0.0464
131 METASTATIC NEOPLASM 200 0.0463
132 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 439 0.0459
133 METASTASIS 327 0.0458
134 VENOUS THROMBOSIS LIMB 94 0.0455
135 LUNG ADENOCARCINOMA 137 0.0455
136 GENE MUTATION 90 0.0454
137 PNEUMOPERITONEUM 84 0.0454
138 LEUKOENCEPHALOPATHY 166 0.0445
139 DIVERTICULAR PERFORATION 91 0.0442
140 VITREOUS FLOATERS 434 0.0441
141 NEUROTOXICITY 772 0.0440
142 NECROTISING FASCIITIS 155 0.0439
143 ACUTE ABDOMEN 64 0.0436
144 ASPARTATE AMINOTRANSFERASE ABNORMAL 65 0.0427
145 TUMOUR PAIN 56 0.0425
146 ILEUS 526 0.0423
147 PARONYCHIA 185 0.0421
148 CEREBRAL ISCHAEMIA 214 0.0415
149 NEUTROPHIL COUNT DECREASED 1693 0.0415
150 LYMPHADENOPATHY MEDIASTINAL 79 0.0412
151 HYPOALBUMINAEMIA 320 0.0411
152 PNEUMATOSIS INTESTINALIS 117 0.0410
153 POLYNEUROPATHY 491 0.0410
154 ARTERIAL THROMBOSIS 79 0.0408
155 NON-SMALL CELL LUNG CANCER 195 0.0407
156 INCISIONAL HERNIA 56 0.0403
157 ENTEROCOLITIS 231 0.0400
158 HYPOPHYSITIS 80 0.0397
159 HEPATIC LESION 172 0.0397
160 SMALL INTESTINAL OBSTRUCTION 489 0.0397
161 ENCEPHALITIS AUTOIMMUNE 52 0.0395
162 CHOLANGITIS 245 0.0395
163 METASTASES TO BONE 647 0.0394
164 GASTROINTESTINAL NECROSIS 114 0.0391
165 VENA CAVA THROMBOSIS 64 0.0385
166 HYDRONEPHROSIS 286 0.0382
167 METASTASES TO SPINE 128 0.0380
168 IMMUNE-MEDIATED ENTEROCOLITIS 140 0.0380
169 RETINAL VEIN OCCLUSION 109 0.0379
170 ONYCHOLYSIS 59 0.0377
171 MEAN CELL HAEMOGLOBIN INCREASED 62 0.0374
172 TUMOUR MARKER INCREASED 179 0.0373
173 INFECTIOUS PLEURAL EFFUSION 56 0.0368
174 NEUTROPHIL COUNT ABNORMAL 104 0.0368
175 ABDOMINAL ABSCESS 159 0.0359
176 NEOPLASM PROGRESSION 1250 0.0359
177 ENTERITIS 230 0.0359
178 JUGULAR VEIN THROMBOSIS 63 0.0354
179 HEPATITIS B REACTIVATION 112 0.0353
180 OVARIAN CANCER 324 0.0351
181 OCULAR HYPERTENSION 68 0.0350
182 VASCULAR PSEUDOANEURYSM 61 0.0350
183 ADRENAL INSUFFICIENCY 421 0.0347
184 HYPERAMMONAEMIC ENCEPHALOPATHY 60 0.0345
185 RETINAL DETACHMENT 317 0.0344
186 ADENOCARCINOMA 77 0.0343
187 HYPERBILIRUBINAEMIA 351 0.0339
188 GASTROINTESTINAL STOMA COMPLICATION 53 0.0337
189 PERIODONTITIS 73 0.0337
190 INTERCEPTED PRODUCT STORAGE ERROR 120 0.0336
191 VENOOCCLUSIVE LIVER DISEASE 166 0.0336
192 ALANINE AMINOTRANSFERASE ABNORMAL 70 0.0332
193 ARTERIOSPASM CORONARY 133 0.0331
194 MEAN CELL VOLUME INCREASED 85 0.0331
195 FEBRILE NEUTROPENIA 2196 0.0331
196 HEPATIC ENCEPHALOPATHY 308 0.0330
197 NEUROPATHY PERIPHERAL 3137 0.0329
198 THYROIDITIS 99 0.0329
199 PNEUMOTHORAX 520 0.0328
200 AZOTAEMIA 130 0.0325
201 AORTIC DISSECTION 133 0.0321
202 ANAL FISTULA 171 0.0320
203 IRIDOCYCLITIS 100 0.0316
204 HYPOPITUITARISM 55 0.0316
205 NEOPLASM RECURRENCE 107 0.0315
206 RED CELL DISTRIBUTION WIDTH INCREASED 131 0.0315
207 SUSPECTED OFF LABEL USE 141 0.0312
208 PERFORMANCE STATUS DECREASED 145 0.0310
209 ABDOMINAL INFECTION 79 0.0309
210 THROMBOCYTOPENIA 3453 0.0308
211 HYPOPHOSPHATAEMIA 228 0.0308
212 INTERCEPTED MEDICATION ERROR 142 0.0306
213 FISTULA 341 0.0303
214 HEPATIC MASS 58 0.0301
215 NEUTROPENIA 4091 0.0301
216 RETINAL ARTERY OCCLUSION 76 0.0301
217 LEUKOPENIA 1493 0.0298
218 DISSEMINATED INTRAVASCULAR COAGULATION 419 0.0297
219 PERITONITIS 615 0.0297
220 NEPHRITIS 99 0.0296
221 RECTAL CANCER 91 0.0296
222 LIVER ABSCESS 96 0.0296
223 HYPERAMMONAEMIA 148 0.0296
224 FEBRILE BONE MARROW APLASIA 124 0.0291
225 HYPOMAGNESAEMIA 406 0.0291
226 LEFT VENTRICULAR DYSFUNCTION 195 0.0291
227 EXPOSED BONE IN JAW 63 0.0290
228 PROCTITIS 81 0.0289
229 EPISTAXIS 2160 0.0288
230 CHOLANGITIS SCLEROSING 59 0.0287
231 URINARY TRACT OBSTRUCTION 68 0.0286
232 PULMONARY HAEMORRHAGE 224 0.0286
233 EYE HAEMORRHAGE 382 0.0286
234 HAEMOLYTIC URAEMIC SYNDROME 66 0.0284
235 RETINAL DISORDER 74 0.0284
236 HEPATIC FAILURE 850 0.0282
237 INTERSTITIAL LUNG DISEASE 1359 0.0280
238 HYPERTENSION 5933 0.0280
239 WOUND COMPLICATION 96 0.0279
240 INTESTINAL OBSTRUCTION 1046 0.0277
241 IMMUNE THROMBOCYTOPENIA 127 0.0277
242 OESOPHAGITIS 303 0.0277
243 IMMUNE-MEDIATED HEPATIC DISORDER 54 0.0277
244 NEOPLASM 318 0.0276
245 HYPOTHYROIDISM 883 0.0276
246 PNEUMONITIS 751 0.0276
247 CAPILLARY LEAK SYNDROME 57 0.0275
248 MALIGNANT NEOPLASM PROGRESSION 2817 0.0275
249 BLINDNESS 1115 0.0273
250 ORAL INTAKE REDUCED 66 0.0273
251 HEPATIC FUNCTION ABNORMAL 998 0.0267
252 NEUTROPENIC SEPSIS 190 0.0266
253 MYOCARDITIS 300 0.0261
254 IRITIS 79 0.0260
255 THROMBOTIC THROMBOCYTOPENIC PURPURA 91 0.0258
256 DUODENAL ULCER 181 0.0256
257 MYOSITIS 230 0.0256
258 INTENTIONAL PRODUCT USE ISSUE 2227 0.0254
259 BREAST CANCER METASTATIC 273 0.0254
260 GLOMERULONEPHRITIS 62 0.0253
261 HYPERTENSIVE CRISIS 281 0.0252
262 RETINAL TEAR 62 0.0251
263 VISUAL ACUITY REDUCED 835 0.0251
264 SUDDEN DEATH 263 0.0248
265 CHANGE OF BOWEL HABIT 51 0.0248
266 EYE INFLAMMATION 237 0.0248
267 STOMATITIS 1506 0.0248
268 INTRAOCULAR PRESSURE INCREASED 317 0.0248
269 ENCEPHALITIS 170 0.0245
270 UVEITIS 330 0.0243
271 CANCER PAIN 62 0.0242
272 OSTEONECROSIS OF JAW 597 0.0241
273 AMYLASE INCREASED 89 0.0241
274 LYMPHOPENIA 340 0.0240
275 RECURRENT CANCER 98 0.0240
276 HAEMOPTYSIS 670 0.0240
277 INTESTINAL ISCHAEMIA 132 0.0239
278 AUTOIMMUNE HAEMOLYTIC ANAEMIA 82 0.0239
279 CACHEXIA 123 0.0239
280 CONJUNCTIVAL HAEMORRHAGE 91 0.0238
281 CHOLECYSTITIS ACUTE 134 0.0236
282 PROCTALGIA 152 0.0236
283 BLOOD BILIRUBIN INCREASED 638 0.0236
284 ANAEMIA 4504 0.0236
285 ACUTE CORONARY SYNDROME 195 0.0235
286 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 686 0.0234
287 CARDIOTOXICITY 208 0.0233
288 FAILURE TO THRIVE 120 0.0231
289 PHOTOPSIA 146 0.0231
290 ILEUS PARALYTIC 103 0.0231
291 NON-CARDIAC CHEST PAIN 73 0.0231
292 ANAL HAEMORRHAGE 64 0.0228
293 ATELECTASIS 220 0.0227
294 OPTIC ISCHAEMIC NEUROPATHY 88 0.0227
295 COLITIS ISCHAEMIC 152 0.0225
296 NECROSIS 124 0.0223
297 DUODENAL ULCER HAEMORRHAGE 63 0.0220
298 LARYNGOSPASM 59 0.0219
299 BLOOD ALBUMIN DECREASED 173 0.0218
300 LYMPHOCYTE COUNT DECREASED 385 0.0218
301 AORTIC ARTERIOSCLEROSIS 56 0.0217
302 HEPATIC NEOPLASM 71 0.0217
303 PLATELET COUNT DECREASED 2296 0.0215
304 PLEURAL EFFUSION 1303 0.0214
305 PULMONARY EMBOLISM 2027 0.0213
306 LUNG NEOPLASM 91 0.0213
307 DYSAESTHESIA 65 0.0212
308 HYPERTRIGLYCERIDAEMIA 124 0.0212
309 MYELODYSPLASTIC SYNDROME 306 0.0211
310 COLITIS 797 0.0210
311 JAUNDICE CHOLESTATIC 74 0.0209
312 HYPOKALAEMIA 962 0.0208
313 WOUND INFECTION 228 0.0208
314 ULCERATIVE KERATITIS 57 0.0208
315 HYPERPYREXIA 85 0.0201
316 BLINDNESS UNILATERAL 282 0.0200
317 SHOCK HAEMORRHAGIC 162 0.0199
318 HEMIPARESIS 337 0.0199
319 IMMUNE THROMBOCYTOPENIC PURPURA 56 0.0198
320 TUMOUR LYSIS SYNDROME 174 0.0198
321 EJECTION FRACTION DECREASED 304 0.0195
322 EXTRAVASATION 80 0.0194
323 DIABETIC RETINOPATHY 66 0.0194
324 TYPE 1 DIABETES MELLITUS 117 0.0194
325 GINGIVAL BLEEDING 264 0.0193
326 ACUTE MYELOID LEUKAEMIA 301 0.0193
327 HAEMORRHOIDAL HAEMORRHAGE 94 0.0192
328 SPLENOMEGALY 225 0.0192
329 DEEP VEIN THROMBOSIS 1246 0.0192
330 IMPAIRED HEALING 626 0.0190
331 HICCUPS 156 0.0190
332 CONGESTIVE CARDIOMYOPATHY 77 0.0185
333 PERIPHERAL ISCHAEMIA 75 0.0183
334 CYSTITIS HAEMORRHAGIC 74 0.0183
335 BONE LESION 66 0.0183
336 CARDIAC DYSFUNCTION 68 0.0183
337 HEPATIC CYST 62 0.0182
338 ASPARTATE AMINOTRANSFERASE INCREASED 969 0.0182
339 HAEMOLYTIC ANAEMIA 163 0.0182
340 SKIN NECROSIS 94 0.0181
341 ISCHAEMIA 83 0.0180
342 PRODUCT CONTAMINATION 64 0.0180
343 ABDOMINAL HERNIA 82 0.0180
344 THROMBOPHLEBITIS 63 0.0180
345 HYPERTHYROIDISM 260 0.0179
346 VISUAL FIELD DEFECT 129 0.0178
347 SUSPECTED COUNTERFEIT PRODUCT 70 0.0177
348 HYPERTRANSAMINASAEMIA 123 0.0177
349 CHOLECYSTITIS 210 0.0176
350 GUILLAIN-BARRE SYNDROME 85 0.0176
351 DEVICE RELATED INFECTION 270 0.0175
352 CARDIOMYOPATHY 258 0.0174
353 ABDOMINAL ADHESIONS 55 0.0174
354 MENINGITIS 116 0.0174
355 EYE INFECTION 196 0.0173
356 HEPATIC CIRRHOSIS 323 0.0172
357 MULTIPLE-DRUG RESISTANCE 53 0.0171
358 ERYTHEMA MULTIFORME 159 0.0170
359 TRANSAMINASES INCREASED 379 0.0170
360 OFF LABEL USE 14881 0.0170
361 PULMONARY TOXICITY 120 0.0170
362 VENTRICULAR HYPOKINESIA 54 0.0168
363 PHLEBITIS 86 0.0168
364 BREAST CANCER RECURRENT 53 0.0168
365 WHITE BLOOD CELL COUNT DECREASED 1816 0.0167
366 EYE DISCHARGE 174 0.0167
367 HYDROCEPHALUS 91 0.0167
368 STRESS CARDIOMYOPATHY 97 0.0167
369 CEREBRAL INFARCTION 407 0.0166
370 BONE MARROW DISORDER 50 0.0165
371 GENERAL PHYSICAL HEALTH DETERIORATION 1901 0.0164
372 FAECALOMA 90 0.0164
373 DRUG RESISTANCE 420 0.0163
374 BLOOD PRESSURE DIASTOLIC INCREASED 75 0.0162
375 CERVIX CARCINOMA 63 0.0161
376 ALANINE AMINOTRANSFERASE INCREASED 987 0.0161
377 ANGIOPATHY 90 0.0160
378 TONGUE ULCERATION 54 0.0160
379 SECOND PRIMARY MALIGNANCY 132 0.0159
380 ANAL FISSURE 85 0.0158
381 LUNG INFILTRATION 138 0.0156
382 LYMPHOEDEMA 108 0.0156
383 BRAIN OEDEMA 197 0.0156
384 NAIL DISORDER 136 0.0155
385 AUTOIMMUNE HEPATITIS 108 0.0155
386 HYPONATRAEMIA 874 0.0155
387 PYELONEPHRITIS 134 0.0154
388 DEATH 13305 0.0154
389 OESOPHAGEAL ULCER 59 0.0153
390 DEHYDRATION 2035 0.0152
391 DECREASED APPETITE 3524 0.0152
392 BLOOD ALKALINE PHOSPHATASE INCREASED 374 0.0150
393 ANAL ABSCESS 81 0.0150
394 LOWER GASTROINTESTINAL HAEMORRHAGE 110 0.0149
395 CYTOPENIA 182 0.0148
396 HAEMATOCRIT DECREASED 292 0.0147
397 BACTERAEMIA 174 0.0146
398 ACUTE PULMONARY OEDEMA 82 0.0146
399 MONOCYTE COUNT INCREASED 53 0.0146
400 NAIL DISCOLOURATION 57 0.0145
401 COLON CANCER 216 0.0145
402 GINGIVITIS 78 0.0144
403 BLINDNESS TRANSIENT 106 0.0144
404 HYPOVOLAEMIA 84 0.0143
405 SKIN ULCER 370 0.0143
406 OESOPHAGEAL CANDIDIASIS 57 0.0143
407 ODYNOPHAGIA 85 0.0142
408 LUNG INFECTION 221 0.0142
409 JAUNDICE 381 0.0141
410 ISCHAEMIC STROKE 251 0.0140
411 KLEBSIELLA INFECTION 71 0.0140
412 HAEMATURIA 480 0.0140
413 HYPOCALCAEMIA 265 0.0140
414 HAEMOGLOBIN ABNORMAL 90 0.0140
415 MYOCARDIAL ISCHAEMIA 159 0.0140
416 BLOOD CREATININE INCREASED 911 0.0139
417 SEPSIS 1550 0.0139
418 HEPATITIS 355 0.0139
419 MOUTH ULCERATION 292 0.0138
420 ELECTROLYTE IMBALANCE 161 0.0138
421 ANAPHYLACTOID REACTION 57 0.0138
422 PULMONARY MASS 206 0.0138
423 PATHOLOGICAL FRACTURE 70 0.0138
424 VENTRICULAR FIBRILLATION 153 0.0138
425 SEPTIC SHOCK 597 0.0137
426 HEMIPLEGIA 113 0.0136
427 HAEMORRHAGE 1420 0.0136
428 MACULAR DEGENERATION 162 0.0136
429 DIVERTICULUM INTESTINAL 59 0.0135
430 NEPHROPATHY TOXIC 151 0.0134
431 RECTAL HAEMORRHAGE 576 0.0134
432 SUPRAVENTRICULAR TACHYCARDIA 128 0.0134
433 CORONARY ARTERY STENOSIS 67 0.0133
434 HAEMATEMESIS 337 0.0133
435 FEMORAL NECK FRACTURE 68 0.0133
436 FLANK PAIN 124 0.0132
437 HEPATOTOXICITY 294 0.0132
438 HAEMORRHAGE INTRACRANIAL 197 0.0132
439 ABSCESS 209 0.0131
440 RASH PUSTULAR 95 0.0130
441 PANCYTOPENIA 727 0.0130
442 PIGMENTATION DISORDER 80 0.0129
443 PERICARDIAL EFFUSION 299 0.0129
444 HYPERURICAEMIA 53 0.0129
445 NO ADVERSE EVENT 2320 0.0128
446 ENCEPHALOPATHY 314 0.0128
447 GASTRIC ULCER 242 0.0127
448 ORGANISING PNEUMONIA 63 0.0127
449 MALNUTRITION 142 0.0127
450 HEPATIC PAIN 54 0.0126
451 GASTRIC ULCER HAEMORRHAGE 70 0.0126
452 CEREBRAL HAEMORRHAGE 452 0.0126
453 ABDOMINAL PAIN 2905 0.0125
454 CARDIAC FAILURE ACUTE 83 0.0124
455 LIVER INJURY 305 0.0124
456 UPPER GASTROINTESTINAL HAEMORRHAGE 209 0.0124
457 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 93 0.0124
458 RENAL IMPAIRMENT 1033 0.0123
459 BLOOD LACTATE DEHYDROGENASE INCREASED 193 0.0122
460 CHOLESTASIS 232 0.0121
461 DYSPHONIA 706 0.0121
462 MELAENA 265 0.0120
463 PYREXIA 4134 0.0119
464 BLOOD MAGNESIUM DECREASED 103 0.0119
465 HYPOXIA 420 0.0119
466 DECUBITUS ULCER 97 0.0119
467 MENTAL STATUS CHANGES 330 0.0119
468 NEUTROPHIL COUNT INCREASED 121 0.0118
469 MUSCULOSKELETAL CHEST PAIN 182 0.0117
470 LIPASE INCREASED 90 0.0117
471 GAMMA-GLUTAMYLTRANSFERASE INCREASED 260 0.0117
472 ABDOMINAL TENDERNESS 58 0.0117
473 LACRIMATION INCREASED 352 0.0116
474 HAEMOGLOBIN DECREASED 1192 0.0116
475 DIARRHOEA 7454 0.0115
476 OSTEONECROSIS 378 0.0115
477 ANOREXIA 148 0.0115
478 ORAL CANDIDIASIS 151 0.0115
479 BODY TEMPERATURE DECREASED 112 0.0114
480 ORAL DISORDER 83 0.0113
481 ACUTE RESPIRATORY DISTRESS SYNDROME 200 0.0113
482 GASTROENTERITIS 164 0.0112
483 NEUROLOGICAL SYMPTOM 64 0.0112
484 SUBARACHNOID HAEMORRHAGE 114 0.0112
485 BRAIN NEOPLASM MALIGNANT 50 0.0112
486 HYPERTHERMIA 85 0.0111
487 RENAL FAILURE ACUTE 472 0.0111
488 HYPOVOLAEMIC SHOCK 53 0.0111
489 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 56 0.0110
490 SINUS TACHYCARDIA 157 0.0110
491 RED BLOOD CELL COUNT DECREASED 315 0.0110
492 HYPERCALCAEMIA 136 0.0110
493 ATAXIA 130 0.0109
494 CONSTIPATION 2386 0.0109
495 LIVER DISORDER 484 0.0109
496 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 112 0.0109
497 THROMBOSIS 877 0.0109
498 HYPERGLYCAEMIA 397 0.0109
499 PARTIAL SEIZURES 57 0.0109
500 HYPERKALAEMIA 381 0.0109
501 ANEURYSM 54 0.0108
502 RENAL CYST 86 0.0108
503 BLOOD DISORDER 86 0.0107
504 CARDIAC FAILURE 860 0.0107
505 SKIN HYPERPIGMENTATION 92 0.0107
506 VOMITING 5028 0.0107
507 ACUTE HEPATIC FAILURE 146 0.0107
508 GASTROINTESTINAL HAEMORRHAGE 892 0.0107
509 TEMPERATURE INTOLERANCE 110 0.0106
510 HAEMORRHOIDS 207 0.0106
511 GASTRIC HAEMORRHAGE 122 0.0106
512 GRANULOCYTOPENIA 60 0.0105
513 DERMATITIS BULLOUS 76 0.0105
514 RENAL FAILURE CHRONIC 80 0.0104
515 ATRIAL FLUTTER 83 0.0104
516 THYROID DISORDER 160 0.0104
517 APHASIA 313 0.0104
518 MULTI-ORGAN FAILURE 179 0.0103
519 ENDOCARDITIS 53 0.0103
520 ULCER 162 0.0102
521 NO THERAPEUTIC RESPONSE 124 0.0102
522 MYASTHENIA GRAVIS 82 0.0101
523 BREATH SOUNDS ABNORMAL 50 0.0101
524 LEUKOCYTOSIS 183 0.0101
525 VISUAL IMPAIRMENT 1241 0.0100
526 UROSEPSIS 92 0.0100
527 ESCHERICHIA INFECTION 82 0.0100
528 PNEUMOCYSTIS JIROVECII PNEUMONIA 100 0.0099
529 RESPIRATORY FAILURE 725 0.0099
530 BRAIN NEOPLASM 91 0.0099
531 SKIN DISORDER 330 0.0099
532 HEPATIC CYTOLYSIS 125 0.0098
533 ORAL PAIN 217 0.0097
534 SPINAL OSTEOARTHRITIS 85 0.0097
535 ASTHENIA 3623 0.0096
536 TRANSIENT ISCHAEMIC ATTACK 325 0.0096
537 CHEILITIS 52 0.0096
538 PLEURISY 57 0.0096
539 FOREIGN BODY SENSATION IN EYES 61 0.0096
540 BLOOD SODIUM DECREASED 180 0.0095
541 MOUTH HAEMORRHAGE 70 0.0095
542 PNEUMONIA ASPIRATION 238 0.0095
543 BLOOD UREA INCREASED 159 0.0095
544 LYMPHADENOPATHY 336 0.0095
545 BLOOD LACTIC ACID INCREASED 50 0.0095
546 ECCHYMOSIS 65 0.0095
547 ANAPHYLACTIC SHOCK 244 0.0095
548 OEDEMA 506 0.0093
549 NEUTROPHILIA 53 0.0093
550 RHINITIS 75 0.0093
551 INFUSION RELATED REACTION 615 0.0093
552 NODULE 121 0.0093
553 DERMATITIS 194 0.0092
554 EYELID PTOSIS 94 0.0092
555 EYE PAIN 519 0.0092
556 PROTHROMBIN TIME PROLONGED 55 0.0092
557 GLAUCOMA 177 0.0092
558 ALTERED STATE OF CONSCIOUSNESS 199 0.0092
559 BLOOD PRESSURE INCREASED 1399 0.0091
560 TOOTH ABSCESS 93 0.0091
561 BODY TEMPERATURE INCREASED 185 0.0091
562 APPETITE DISORDER 60 0.0090
563 GINGIVAL PAIN 72 0.0090
564 CONVULSION 512 0.0089
565 DYSPNOEA EXERTIONAL 336 0.0089
566 EPILEPSY 272 0.0089
567 GENERALISED OEDEMA 110 0.0089
568 AGRANULOCYTOSIS 165 0.0089
569 RASH MACULO-PAPULAR 197 0.0088
570 INFECTION 1279 0.0088
571 CATARACT 525 0.0088
572 BLOOD THYROID STIMULATING HORMONE INCREASED 81 0.0088
573 METABOLIC DISORDER 51 0.0088
574 DIARRHOEA HAEMORRHAGIC 82 0.0088
575 HEPATOCELLULAR INJURY 124 0.0087
576 NEOPLASM MALIGNANT 580 0.0087
577 CIRCULATORY COLLAPSE 148 0.0087
578 HYPOPHAGIA 221 0.0086
579 EYE DISORDER 284 0.0086
580 TOOTH EXTRACTION 107 0.0086
581 DIVERTICULITIS 238 0.0086
582 HAEMOLYSIS 66 0.0085
583 MULTIPLE ORGAN DYSFUNCTION SYNDROME 242 0.0085
584 FATIGUE 6621 0.0085
585 DUODENAL ULCER PERFORATION 63 0.0085
586 OCULAR DISCOMFORT 95 0.0085
587 DRY THROAT 86 0.0085
588 BLOOD PRESSURE SYSTOLIC INCREASED 165 0.0085
589 TENDERNESS 88 0.0084
590 GENERAL PHYSICAL CONDITION ABNORMAL 57 0.0084
591 NAUSEA 6613 0.0083
592 VASCULITIS 97 0.0083
593 TROPONIN INCREASED 63 0.0083
594 PANCREATITIS ACUTE 186 0.0083
595 BRONCHOSPASM 118 0.0083
596 PULMONARY HYPERTENSION 172 0.0082
597 SPINAL COMPRESSION FRACTURE 68 0.0082
598 GASTRITIS 215 0.0082
599 SKIN REACTION 115 0.0082
600 ACIDOSIS 62 0.0081
601 GASTROINTESTINAL DISORDER 725 0.0081
602 CYTOKINE RELEASE SYNDROME 162 0.0081
603 C-REACTIVE PROTEIN INCREASED 293 0.0080
604 ASPIRATION 88 0.0080
605 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 440 0.0080
606 AORTIC ANEURYSM 61 0.0080
607 WHITE BLOOD CELL COUNT ABNORMAL 51 0.0080
608 BONE DISORDER 145 0.0079
609 MITRAL VALVE INCOMPETENCE 90 0.0079
610 GRAND MAL CONVULSION 73 0.0079
611 COAGULOPATHY 131 0.0079
612 NERVOUS SYSTEM DISORDER 244 0.0078
613 DRUG ERUPTION 138 0.0078
614 HEPATIC STEATOSIS 145 0.0078
615 ARTERIOSCLEROSIS 73 0.0077
616 SHOCK 178 0.0077
617 POSTOPERATIVE WOUND INFECTION 52 0.0077
618 EOSINOPHIL COUNT INCREASED 64 0.0077
619 GASTROINTESTINAL INFLAMMATION 60 0.0077
620 OEDEMA PERIPHERAL 929 0.0076
621 RENAL FAILURE 1011 0.0076
622 FRACTURE 144 0.0076
623 APHTHOUS ULCER 59 0.0076
624 BLOOD URINE PRESENT 144 0.0076
625 PURPURA 67 0.0076
626 ACUTE MYOCARDIAL INFARCTION 223 0.0076
627 TOXIC SKIN ERUPTION 76 0.0075
628 ILL-DEFINED DISORDER 455 0.0075
629 ACUTE KIDNEY INJURY 1143 0.0075
630 APPENDICITIS 69 0.0074
631 PETECHIAE 77 0.0074
632 PANCREATITIS 389 0.0074
633 PULMONARY THROMBOSIS 80 0.0073
634 ACUTE RESPIRATORY FAILURE 141 0.0073
635 TUBULOINTERSTITIAL NEPHRITIS 137 0.0073
636 APHONIA 102 0.0073
637 HAEMORRHAGIC STROKE 57 0.0073
638 MUSCULOSKELETAL PAIN 382 0.0073
639 ATRIAL FIBRILLATION 705 0.0072
640 EMPHYSEMA 73 0.0072
641 DYSPHAGIA 686 0.0072
642 DYSURIA 266 0.0072
643 TACHYCARDIA 642 0.0072
644 BLOOD PRESSURE DIASTOLIC DECREASED 53 0.0072
645 WEIGHT DECREASED 2002 0.0072
646 DISEASE RECURRENCE 341 0.0072
647 TASTE DISORDER 145 0.0071
648 DRUG-INDUCED LIVER INJURY 224 0.0071
649 TOOTHACHE 129 0.0071
650 CARDIO-RESPIRATORY ARREST 295 0.0070
651 HYPERCHOLESTEROLAEMIA 68 0.0070
652 SKIN INFECTION 79 0.0070
653 RENAL TUBULAR NECROSIS 69 0.0070
654 LUNG DISORDER 343 0.0070
655 PULMONARY FIBROSIS 134 0.0070
656 POST PROCEDURAL COMPLICATION 134 0.0070
657 THROAT TIGHTNESS 188 0.0069
658 BLOOD POTASSIUM DECREASED 206 0.0068
659 MYOPATHY 59 0.0068
660 RESPIRATORY DISTRESS 188 0.0068
661 URINARY TRACT INFECTION 1160 0.0068
662 POST PROCEDURAL HAEMORRHAGE 79 0.0068
663 BLOOD TEST ABNORMAL 95 0.0068
664 ABDOMINAL PAIN LOWER 170 0.0067
665 BONE PAIN 393 0.0067
666 THERAPY NON-RESPONDER 300 0.0067
667 BLOOD CALCIUM DECREASED 75 0.0067
668 DIPLOPIA 173 0.0067
669 BACTERIAL INFECTION 123 0.0066
670 NEPHROPATHY 61 0.0065
671 FACE OEDEMA 110 0.0065
672 CANDIDA INFECTION 110 0.0065
673 OCULAR HYPERAEMIA 308 0.0065
674 ALOPECIA 1268 0.0065
675 DENTAL CARIES 71 0.0064
676 CELLULITIS 322 0.0064
677 PULMONARY OEDEMA 286 0.0064
678 CHILLS 741 0.0063
679 HAEMATOCHEZIA 348 0.0063
680 SKIN FISSURES 123 0.0063
681 PNEUMONIA 2037 0.0063
682 STATUS EPILEPTICUS 71 0.0063
683 CONFUSIONAL STATE 1014 0.0063
684 PHOTOPHOBIA 118 0.0063
685 MUSCULAR WEAKNESS 711 0.0062
686 ASPHYXIA 51 0.0062
687 NEURALGIA 150 0.0062
688 DYSPNOEA 3466 0.0061
689 DYSARTHRIA 230 0.0061
690 HYPERLIPIDAEMIA 73 0.0061
691 PAIN IN JAW 173 0.0061
692 HEPATOMEGALY 60 0.0061
693 SYNCOPE 605 0.0060
694 INTERNATIONAL NORMALISED RATIO INCREASED 172 0.0060
695 OSTEOMYELITIS 108 0.0060
696 OXYGEN SATURATION DECREASED 335 0.0060
697 LIVER FUNCTION TEST ABNORMAL 173 0.0059
698 ANGINA PECTORIS 170 0.0059
699 CEREBROVASCULAR ACCIDENT 1003 0.0059
700 FOLLICULITIS 62 0.0059
701 IMMUNODEFICIENCY 88 0.0059
702 CYANOSIS 92 0.0058
703 HYPOTENSION 1163 0.0058
704 RENAL DISORDER 270 0.0058
705 ANAPHYLACTIC REACTION 320 0.0058
706 DYSGEUSIA 427 0.0057
707 HYPOAESTHESIA 857 0.0057
708 MASS 80 0.0057
709 PHARYNGEAL OEDEMA 88 0.0057
710 IMMUNE SYSTEM DISORDER 75 0.0057
711 SINUS BRADYCARDIA 55 0.0057
712 VISION BLURRED 781 0.0057
713 PARAESTHESIA 893 0.0057
714 PNEUMONIA BACTERIAL 52 0.0057
715 TACHYPNOEA 77 0.0057
716 DEPRESSED LEVEL OF CONSCIOUSNESS 223 0.0056
717 SPEECH DISORDER 295 0.0056
718 EYE PRURITUS 189 0.0056
719 PARALYSIS 80 0.0056
720 RASH 2426 0.0056
721 CHEST PAIN 1025 0.0055
722 HYPOTHERMIA 56 0.0055
723 CYSTITIS 176 0.0055
724 SEIZURE 637 0.0055
725 CONJUNCTIVITIS 102 0.0055
726 LIVER FUNCTION TEST INCREASED 118 0.0055
727 RESPIRATORY TRACT INFECTION 143 0.0055
728 PERICARDITIS 92 0.0055
729 CLOSTRIDIUM DIFFICILE COLITIS 58 0.0055
730 ORTHOSTATIC HYPOTENSION 95 0.0055
731 INFLAMMATION 278 0.0054
732 BACK PAIN 1249 0.0054
733 HAEMATOMA 139 0.0054
734 FEEDING DISORDER 108 0.0053
735 TOOTH INFECTION 70 0.0053
736 URINARY RETENTION 177 0.0053
737 PELVIC PAIN 96 0.0053
738 ABDOMINAL DISTENSION 551 0.0053
739 CARDIAC ARREST 434 0.0053
740 WHITE BLOOD CELL COUNT INCREASED 199 0.0052
741 HYPERSENSITIVITY 962 0.0052
742 PLATELET COUNT INCREASED 67 0.0051
743 PRODUCTIVE COUGH 245 0.0051
744 COUGH 1439 0.0051
745 CHOLELITHIASIS 168 0.0051
746 SPINAL PAIN 60 0.0051
747 RHINORRHOEA 330 0.0051
748 PERIPHERAL COLDNESS 70 0.0051
749 ARRHYTHMIA 240 0.0051
750 CARDIOMEGALY 62 0.0050
751 GASTROINTESTINAL PAIN 55 0.0050
752 INTERNAL HAEMORRHAGE 57 0.0050
753 SENSORY DISTURBANCE 80 0.0050
754 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0050
755 EYE IRRITATION 285 0.0049
756 SINUS CONGESTION 66 0.0049
757 DRUG INTOLERANCE 468 0.0048
758 TOXICITY TO VARIOUS AGENTS 815 0.0048
759 DELIRIUM 167 0.0048
760 CENTRAL NERVOUS SYSTEM LESION 66 0.0048
761 DEAFNESS 125 0.0048
762 COGNITIVE DISORDER 221 0.0047
763 STEVENS-JOHNSON SYNDROME 105 0.0047
764 LETHARGY 271 0.0047
765 WOUND 131 0.0047
766 OBSTRUCTIVE AIRWAYS DISORDER 52 0.0047
767 DRUG TOXICITY 63 0.0046
768 URINARY INCONTINENCE 136 0.0046
769 COMA 218 0.0046
770 HERPES ZOSTER 260 0.0045
771 COVID-19 PNEUMONIA 53 0.0045
772 BLOOD PRESSURE ABNORMAL 89 0.0045
773 ORAL HERPES 87 0.0045
774 ABDOMINAL PAIN UPPER 913 0.0044
775 STAPHYLOCOCCAL INFECTION 146 0.0044
776 ERYTHEMA 909 0.0044
777 EAR PAIN 85 0.0044
778 UPPER RESPIRATORY TRACT INFECTION 201 0.0043
779 LUNG NEOPLASM MALIGNANT 178 0.0043
780 HEPATIC ENZYME INCREASED 295 0.0043
781 DRY EYE 216 0.0043
782 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
783 PALLOR 117 0.0043
784 DIABETIC KETOACIDOSIS 103 0.0043
785 RESPIRATORY DISORDER 128 0.0043
786 DYSPEPSIA 413 0.0042
787 MYOCARDIAL INFARCTION 731 0.0042
788 FAECES DISCOLOURED 90 0.0041
789 SUBDURAL HAEMATOMA 59 0.0041
790 MOVEMENT DISORDER 132 0.0041
791 OROPHARYNGEAL PAIN 380 0.0041
792 DISCOMFORT 249 0.0041
793 MALAISE 1789 0.0041
794 CLOSTRIDIUM DIFFICILE INFECTION 89 0.0041
795 CARDIOGENIC SHOCK 58 0.0040
796 TREATMENT FAILURE 334 0.0040
797 BLOOD COUNT ABNORMAL 61 0.0040
798 LOCAL SWELLING 70 0.0040
799 DISORIENTATION 158 0.0040
800 SCAR 68 0.0040
801 INCORRECT PRODUCT STORAGE 52 0.0040
802 BLOOD POTASSIUM INCREASED 64 0.0039
803 CARDIAC FAILURE CONGESTIVE 313 0.0039
804 VERTIGO 237 0.0039
805 OSTEOPENIA 59 0.0039
806 METABOLIC ACIDOSIS 124 0.0039
807 MYALGIA 653 0.0038
808 RIB FRACTURE 79 0.0038
809 CARDIOVASCULAR DISORDER 97 0.0038
810 VENTRICULAR TACHYCARDIA 63 0.0038
811 PAIN 2339 0.0038
812 BEDRIDDEN 50 0.0038
813 HEADACHE 2377 0.0038
814 BALANCE DISORDER 327 0.0038
815 EYE SWELLING 140 0.0038
816 PRESYNCOPE 91 0.0037
817 VIRAL INFECTION 124 0.0037
818 FULL BLOOD COUNT DECREASED 75 0.0037
819 INTERVERTEBRAL DISC PROTRUSION 81 0.0037
820 CYTOMEGALOVIRUS INFECTION 61 0.0037
821 BRADYCARDIA 193 0.0036
822 NIGHT SWEATS 117 0.0036
823 TOXIC EPIDERMAL NECROLYSIS 55 0.0036
824 DRY MOUTH 293 0.0036
825 CHEST DISCOMFORT 362 0.0035
826 DRY SKIN 470 0.0035
827 GASTROOESOPHAGEAL REFLUX DISEASE 281 0.0035
828 MUSCULOSKELETAL DISCOMFORT 60 0.0035
829 CORONARY ARTERY DISEASE 105 0.0035
830 HYPOGLYCAEMIA 168 0.0035
831 SKIN LESION 95 0.0035
832 NECK PAIN 193 0.0034
833 PRODUCT USE ISSUE 649 0.0034
834 BRAIN FOG 54 0.0034
835 HYPERSOMNIA 98 0.0034
836 THERAPEUTIC RESPONSE DECREASED 206 0.0034
837 HEART RATE DECREASED 119 0.0034
838 ARTHRALGIA 1408 0.0034
839 EATING DISORDER 72 0.0034
840 BLOOD PRESSURE DECREASED 222 0.0033
841 RETCHING 71 0.0033
842 PAIN IN EXTREMITY 979 0.0033
843 EOSINOPHILIA 58 0.0033
844 CONTUSION 316 0.0033
845 FLUSHING 333 0.0033
846 OBESITY 52 0.0033
847 POOR QUALITY SLEEP 70 0.0032
848 BLOOD PRESSURE FLUCTUATION 78 0.0032
849 OSTEOARTHRITIS 136 0.0032
850 TOOTH DISORDER 71 0.0032
851 LOSS OF CONSCIOUSNESS 408 0.0032
852 RASH ERYTHEMATOUS 152 0.0032
853 GAIT DISTURBANCE 605 0.0032
854 PRODUCT USE IN UNAPPROVED INDICATION 780 0.0031
855 FALL 1046 0.0031
856 HEPATIC CANCER 75 0.0031
857 NASOPHARYNGITIS 573 0.0031
858 FLATULENCE 176 0.0031
859 AGEUSIA 77 0.0031
860 COLD SWEAT 54 0.0031
861 DIABETES MELLITUS 233 0.0031
862 TOOTH LOSS 63 0.0030
863 HEART RATE INCREASED 301 0.0030
864 ABASIA 75 0.0030
865 SINUS DISORDER 60 0.0030
866 SKIN EXFOLIATION 254 0.0030
867 HIP FRACTURE 96 0.0030
868 FEMUR FRACTURE 92 0.0030
869 FUNGAL INFECTION 99 0.0030
870 LOWER RESPIRATORY TRACT INFECTION 135 0.0030
871 RENAL INJURY 88 0.0030
872 SKIN DISCOLOURATION 134 0.0029
873 VAGINAL HAEMORRHAGE 125 0.0029
874 TINNITUS 132 0.0029
875 HYPERHIDROSIS 370 0.0029
876 MUSCLE TWITCHING 66 0.0029
877 HERNIA 55 0.0028
878 DIZZINESS 1417 0.0028
879 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 148 0.0028
880 LABORATORY TEST ABNORMAL 83 0.0028
881 ARTHRITIS 221 0.0028
882 ADVERSE EVENT 258 0.0028
883 BRONCHITIS 207 0.0028
884 SPINAL FRACTURE 56 0.0028
885 FEELING HOT 171 0.0028
886 POLLAKIURIA 115 0.0028
887 CONDITION AGGRAVATED 838 0.0028
888 CHROMATURIA 62 0.0027
889 GLOSSODYNIA 61 0.0027
890 GAIT INABILITY 91 0.0027
891 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 192 0.0027
892 FEELING COLD 75 0.0027
893 AMNESIA 175 0.0027
894 ABDOMINAL DISCOMFORT 449 0.0027
895 CARDIAC DISORDER 250 0.0027
896 LOCALISED INFECTION 64 0.0026
897 PRURITUS 1005 0.0026
898 SLEEP DISORDER 183 0.0026
899 RHABDOMYOLYSIS 108 0.0026
900 HYPOACUSIS 111 0.0026
901 DRUG INEFFECTIVE 3323 0.0025
902 INSOMNIA 654 0.0025
903 SWELLING 229 0.0024
904 BREAST CANCER 224 0.0024
905 UNRESPONSIVE TO STIMULI 62 0.0024
906 LIMB DISCOMFORT 74 0.0024
907 RESPIRATORY ARREST 65 0.0024
908 RASH PRURITIC 127 0.0023
909 SOMNOLENCE 471 0.0023
910 BLISTER 131 0.0023
911 UNEVALUABLE EVENT 175 0.0023
912 HEART RATE IRREGULAR 52 0.0023
913 LIMB INJURY 62 0.0023
914 MENTAL DISORDER 99 0.0023
915 NEPHROLITHIASIS 104 0.0023
916 ANXIETY 645 0.0023
917 MOBILITY DECREASED 160 0.0022
918 WHEEZING 132 0.0022
919 MEDICATION ERROR 123 0.0022
920 PAIN OF SKIN 59 0.0022
921 MUSCLE SPASMS 398 0.0022
922 DEPRESSION 489 0.0021
923 COLORECTAL CANCER 102 0.0021
924 MEMORY IMPAIRMENT 293 0.0021
925 SINUSITIS 218 0.0021
926 DEMENTIA 59 0.0021
927 EMOTIONAL DISORDER 65 0.0021
928 RESTLESSNESS 77 0.0021
929 PALPITATIONS 246 0.0021
930 CHRONIC KIDNEY DISEASE 157 0.0021
931 DRUG EFFECT INCOMPLETE 75 0.0021
932 NASAL CONGESTION 121 0.0021
933 INFLUENZA LIKE ILLNESS 168 0.0020
934 THERAPEUTIC PRODUCT EFFECT DECREASED 91 0.0020
935 HOT FLUSH 151 0.0020
936 TREMOR 330 0.0020
937 SWELLING FACE 128 0.0020
938 PERIPHERAL SWELLING 302 0.0020
939 DEPRESSED MOOD 103 0.0019
940 WEIGHT INCREASED 434 0.0019
941 SWOLLEN TONGUE 60 0.0019
942 COVID-19 333 0.0019
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 91 0.0019
944 FREQUENT BOWEL MOVEMENTS 51 0.0019
945 BLOOD CHOLESTEROL INCREASED 88 0.0019
946 ANGIOEDEMA 83 0.0019
947 ACNE 141 0.0019
948 RASH MACULAR 64 0.0018
949 FLUID RETENTION 93 0.0018
950 DRUG INTERACTION 283 0.0018
951 TYPE 2 DIABETES MELLITUS 59 0.0018
952 ELECTROCARDIOGRAM QT PROLONGED 63 0.0017
953 DYSSTASIA 51 0.0017
954 GASTRIC DISORDER 59 0.0017
955 THROAT IRRITATION 75 0.0017
956 ADVERSE DRUG REACTION 150 0.0017
957 PRODUCT STORAGE ERROR 145 0.0017
958 COLITIS ULCERATIVE 74 0.0017
959 BURNING SENSATION 116 0.0017
960 MUSCULOSKELETAL STIFFNESS 143 0.0016
961 HEAD INJURY 51 0.0016
962 URTICARIA 269 0.0016
963 INFLUENZA 179 0.0016
964 MIGRAINE 153 0.0016
965 SURGERY 92 0.0016
966 LIP SWELLING 52 0.0016
967 PRODUCT QUALITY ISSUE 212 0.0016
968 AGITATION 114 0.0016
969 BLOOD GLUCOSE INCREASED 290 0.0015
970 DRUG EFFECT DECREASED 81 0.0015
971 HALLUCINATION 111 0.0015
972 OSTEOPOROSIS 59 0.0014
973 ARTHROPATHY 79 0.0014
974 INJURY 99 0.0014
975 DISTURBANCE IN ATTENTION 73 0.0014
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 234 0.0013
977 ILLNESS 129 0.0013
978 TREATMENT NONCOMPLIANCE 67 0.0012
979 BLOOD GLUCOSE DECREASED 57 0.0012
980 FEELING ABNORMAL 274 0.0011
981 ASTHMA 129 0.0011
982 JOINT SWELLING 126 0.0010
983 UNDERDOSE 76 0.0010
984 INTENTIONAL PRODUCT MISUSE 85 0.0010
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55 0.0008
986 EMOTIONAL DISTRESS 91 0.0008
987 PROSTATE CANCER 57 0.0007
988 OVERDOSE 139 0.0006
989 PSORIASIS 75 0.0006
990 PRODUCT DOSE OMISSION ISSUE 150 0.0005
991 HOSPITALISATION 78 0.0005
992 DRUG DOSE OMISSION 63 0.0004
993 INJECTION SITE PAIN 116 0.0004
994 INCORRECT DOSE ADMINISTERED 77 0.0003
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003